共 50 条
- [11] Hemophagocytic Lymphohistiocytosis in Malignant Hematology: Uncommon but Should Not Be Forgotten? CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S147 - S150
- [12] Treatment of malignant hematology diseases with all transretinoic acid PRESSE MEDICALE, 1997, 26 (29): : 1399 - 1405
- [13] Hemophagocytic Lymphohistiocytosis (HLH) in Malignant Hematology: Uncommon but Should Not be Forgotten? CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S227 - S227
- [14] The Financial Toxicity of FDA-Drugs Approved for Malignant Hematology BLOOD, 2022, 140 : 13285 - 13286
- [16] The Financial Toxicity of FDA-Drugs Approved for Malignant Hematology CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S383 - S383
- [20] Evaluation of Voriconazole Therapeutic Drug Monitoring in Malignant Hematology Patients CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (02): : 137 - 137